SCHEMBL6132918

SCHEMBL6132918

CCCC(OC)OC1CCN(c2ccc(-c3nn4cc(-c5ccc(C(=O)O)cc5)nc4s3)cc2)CC1

nearest known ligand 0.40

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MAPT P10636 13/20 0.40
TP53 P04637 3/20 0.39
CA12 O43570 4/20 0.39
CA1 P00915 4/20 0.39
CA2 P00918 4/20 0.39
CA9 Q16790 4/20 0.39
GAA P10253 1/20 0.38
THRB P10828 2/20 0.37
LMNA P02545 3/20 0.37
CHEK1 O14757 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6132850 0.89 MAPT (0.38) MAPTTP53CA12CA1CA2
SCHEMBL6132775 0.86 MAPT (0.42) MAPTTP53CA12CA1CA2
SCHEMBL6134575 0.85 TP53 (0.43) MAPTTP53CA12CA1CA2
SCHEMBL6134854 0.85 TP53 (0.45) MAPTTP53CA12CA1CA2
SCHEMBL6133896 0.84 TP53 (0.42) MAPTTP53CA12CA1CA2
SCHEMBL6134951 0.81 CA12 (0.52) MAPTTP53CA12CA1CA2
SCHEMBL6132169 0.81 MAPT (0.43) MAPTTP53CA12CA1CA2
SCHEMBL6132626 0.81 TP53 (0.46) MAPTTP53CA12CA1CA2
SCHEMBL6134517 0.78 TP53 (0.50) MAPTTP53CA12CA1CA2
SCHEMBL6135097 0.77 MAPT (0.45) MAPTTP53CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6884868-B1 Cyclic hexapeptides having antibiotic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-04-26 US disclosed
EP-1173472-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-01-23 EP disclosed
WO-2000064927-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-11-02 WO disclosed